Post-approval studies (Phase 4)Study completedNCT02274662What this trial is testingExpanded Access Protocol Thymus TransplantationWho this might be right forPoor Thymic FunctionImmunodeficiencyAthymia+3 more Sumitomo Pharma Switzerland GmbH 11